Background Attention deficit hyperactivity disorder (ADHD) is a common
neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the …

Objective: To review the pathophysiology, etiology, and treatment of attention-deficit
hyperactivity disorder (ADHD). Data Sources and Data Extraction: A literature search was …

Written for practitioners in the field, this critically acclaimed bestseller provides authoritative
information focused on the investigation of drug-related deaths and practical approaches to …

Aim To test the efficacy and safety of osmotic release oral system (OROS) methylphenidate
(MPH) in doses up to 180 mg/day to treat attention deficit hyperactivity disorder (ADHD) and …

Attention deficit hyperactivity disorder (ADHD) is a common neurobehavioral disorder of
childhood that can result in significant functional impairment, and if not adequately treated …

The Psychiatric Consultation Service at Massachusetts General Hospital (MGH) sees
medical and surgical inpatients with comorbid psychiatric symptoms and conditions. Such …

Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioural disorder with
onset during childhood. It affects a child's development, both at home and at school, and …

J Clin Hypertens (Greenwich). 2011; 13: 774–779.© 2011 Wiley Periodicals, Inc. The
purpose of the study was to investigate blood pressure (BP) distribution, prevalence of …

目的观察中枢神经兴奋剂盐酸哌甲酯控释片对儿童注意缺陷多动障碍(ADHD) 的临床疗效.
方法2005 年6 月-2008 年12 月在本科儿童多动症门诊就诊的ADHD 患儿113 例. 男87 例, 女26 …

Background Methylphenidate (MPH), along with behavioral and psychosocial interventions,
is the first-line medication to treat attention-deficit hyperactivity disorder (ADHD) in Sweden …